Florida H0367 establishes caps on cost-sharing for insulin and diabetes supplies in health insurance policies.

Florida H0367 creates a new statute defining "cost-sharing requirement" as an insured's deductible, coinsurance, copayment, or similar out-of-pocket expense. It applies to all health insurance policies delivered, issued, renewed, or amended in Florida on or after January 1, 2027. The bill prohibits health insurance policies from imposing cost-sharing requirements exceeding $35 for a 30-day supply of insulin and $100 for 30 days of diabetes supplies, including blood-glucose test strips, glucometers, continuous glucometers, lancets, and lancing devices. The act takes effect July 1, 2026.

Florida H0367 establishes caps on cost-sharing for insulin and diabetes supplies in health insurance policies.

Florida H0367 creates a new statute defining "cost-sharing requirement" as an insured's deductible, coinsurance, copayment, or similar out-of-pocket expense. It applies to all health insurance policies delivered, issued, renewed, or amended in Florida on or after January 1, 2027. The bill prohibits health insurance policies from imposing cost-sharing requirements exceeding $35 for a 30-day supply of insulin and $100 for 30 days of diabetes supplies, including blood-glucose test strips, glucometers, continuous glucometers, lancets, and lancing devices. The act takes effect July 1, 2026.